FDA staff concerned about safety of Endo's testosterone injection
(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and immediate post-injection adverse events.
Date: Thursday, 04 30, 2020; Speaker: Staff NIH Library; This class is presented as a webinar only; Videocast Event
Date: Monday, 03 30, 2020; Speaker: R. Burke Squires, Mr., NIAID / OCICB / BCBB; Webinar Only; Videocast Event
Date: Thursday, 04 02, 2020; Speaker: Staff NIH Library; This class is presented as a webinar only. ; Videocast Event
Date: Thursday, 04 09, 2020; Speaker: Zeynup Gumus, Assistant Professor, Ichan School of Medicine at Mount Sinai; https://cbiit.webex.com/mw3300/mywebex/default.do?
Date: Wednesday, 04 22, 2020; Speaker: Staff NIH Library; This class is presented as a webinar only. ; Videocast Event
A group of moderately ill people were given hydroxychloroquine, which appeared to ease their symptoms quickly, but more research is needed.
A member of the Arkansas House said Wednesday he's tested positive for the coronavirus and state health officials reported two more people have died from the outbreak.
Publication date: May 2020Source: Molecular Immunology, Volume 121Author(s): Lingmin Huang, Ruiheng Luo, Jing Li, Dan Wang, Yening Zhang, Liping Liu, Ningjie Zhang, Xueming Xu, Ben Lu, Kai Zhao
Publication date: Available online 1 April 2020Source: Autoimmunity ReviewsAuthor(s): Klaus Wirth, Carmen Scheibenbogen
Publication date: Available online 1 April 2020Source: Analytic Methods in Accident ResearchAuthor(s): Mouyid Islam, Fred Mannering